Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society
Kardiologia Polska · 2023
DOI: 10.33963/kp.a2023.0022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kardiologia Polska, 2023. Verfasst von Iwona Gorczyca-Głowacka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland. iwona.gorczyca@interia.pl. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Liver Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
The diagnosis of metabolic associated fatty liver disease (MAFLD) is significant for patients' prognosis, as the disease accelerates the development of cardiovascular complications and, on the other hand, cardiometabolic conditions are risk factors for the development of fatty liver diseases. This expert opinion presents principles of MAFLD diagnosis and standards of management to reduce cardiovascular risks in patients with MAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland. iwona.gorczyca@interia.pl.
- 3rd Department of Internal Diseases and Cardiology, Warsaw Medical University, Warszawa, Poland.
- Institute of Clinical Sciences, Maria Sklodowska-Curie Medical Academy in Warsaw, Warszawa, Poland.
- Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland.
- 1st Department of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Center in Kielce, Kielce, Poland.
- Department of Internal Diseases and Cardiological Physiotherapy, Medical University in Lodz, Łódź, Poland.
Zitieren
APA
Gorczyca-Głowacka, I., Wełnicki, M., Mamcarz, A., Filipiak, K. J., Wożakowska-Kapłon, B., Barylski, M., Szymański, F. M., Kasprzak, J. D., & Tomasiewcz, K. (2023). Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society. Kardiologia Polska. https://doi.org/10.33963/kp.a2023.0022
Vancouver
Gorczyca-Głowacka I, Wełnicki M, Mamcarz A, Filipiak KJ, Wożakowska-Kapłon B, Barylski M, et al. Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society. Kardiologia Polska. 2023. doi:10.33963/kp.a2023.0022
BibTeX
@article{GorczycaGowacka2023,
author = {Gorczyca-Głowacka, Iwona and Wełnicki, Marcin and Mamcarz, Artur and Filipiak, Krzysztof J and Wożakowska-Kapłon, Beata and Barylski, Marcin and Szymański, Filip M and Kasprzak, Jarosław D and Tomasiewcz, Krzysztof},
title = {Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society},
journal = {Kardiologia Polska},
year = {2023},
doi = {10.33963/kp.a2023.0022}
}
EUVIMED